Jurnal Surya Medika (JSM)
metadata only
Analisis Efektivitas Biaya Terapi Kombinasi Mood Stabilizer dan Antipsikotik pada Pasien Gangguan Afektif Bipolar di Rawat Inap RSJ Grhasia Yogyakarta: Cost Effectiveness Analysis of Combination Mood Stabilizer and Antipsychotic Therapy In Bipolar Affective Disorder Patients at Grhasia Mental Hospital Yogyakarta
Bipolar affective disorder is an episodic mental disorder characterized by manic, hypomanic, depressive, and mixed episodes, usually recurring and can last a lifetime. Patients with bipolar disorder have annual medical costs that were four times those of patients without bipolar disorder. The aim of
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Registry of Treatment Adherence for Patients With Schizophrenia#872264
- Work package 3: the clinical and cost-effectiveness of Mental Health Interventions for Children with Epilepsy#337982
- Discontinuation Study Of Citalopram (Antidepressant) in Depressed Adolescents#1046477
- Development and Application of Comprehensive Intervention Techniques for Adolescent Depression#1046438
- Pengaruh Kualitas Pelayanan, Kehandalan, Cepat Tanggap, Dan Jaminan Terhadap Loyalitas Konsumen Pt. Karya Murni Perkasa Medan#1018061
Record · ID 1003796
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive